GCP ICH E6 R3 Unveiled: Navigating the Evolving Roles of Sponsors and CROs

Discover an informative webinar that will explore the structural and content changes introduced in ICH E6 R3 and their impact on current systems and processes.

On January 6, 2025, a new revision (R3) was finalized and is now in the implementation phase, during which regulators will define its mandatory adoption timeline.

A key focus of this webinar will be the revised roles and responsibilities of clinical research organizations (CROs) and sponsors, including shifts in study oversight, risk-based quality management and accountability. Experts will provide insights on adapting to these changes to ensure continuous compliance and regulatory acceptance while optimizing trial efficiency and integrity.

Register for this webinar to gain expert insights on navigating ICH E6 R3 and staying ahead in clinical trial compliance.

Keywords: Clinical Trials, Drug Development, Good Clinical Practice, Clinical Research, CRO, ICH E6, Regulatory, GCP, Sponsors, ICH-E6(R2), Decentralized Clinical Trials, DCT, Quality

Others Details

Life Sciences,Clinical Trials,Pharmaceutical Regulation